YOLO - Cannabis Stocks And ETFs Surge As DEA Moves To Reschedule Marijuana | Benzinga
The cannabis sector saw a notable upswing on Tuesday on news that the Drug Enforcement Administration's (DEA) historic decision to align its stance with a recommendation from the Department of Health and Human Services and move marijuana from Schedule I to Schedule III under the Controlled Substances Act (CSA).
Earlier this year Dept. of Health and Human Services (HHS) released 252 pages of documents earlier this year confirming for the first time that the HHS recommended that the DEA reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act.
The documents explained that cannabis “has a currently accepted medical use in treatment in the United States” and that it has a “potential for abuse less than the drugs or other substances in Schedules I and II."
Now, investors seem optimistic about potential regulatory changes that could benefit the cannabis industry.
Pro tip: Learn all about the future of the cannabis industry ...